Biotech Updates

Australia's OGTR Receives Application for Commercial Release of GM Chrysanthemum

April 20, 2022

The Australian Office of the Gene Technology Regulator (OGTR) has received a license application (DIR 191) from the International Flower Developments for the commercial release of genetically modified (GM) chrysanthemum with altered flower color.

License application DIR 191 is for the commercial import and distribution of cut flowers of GM chrysanthemum altered for flower color. International Flower Developments seeks approval to sell the GM chrysanthemum Australia-wide. The GM chrysanthemums are intended for ornamental use and would not enter commercial human food or animal feed.

The OGTR is preparing a Risk Assessment and Risk Management Plan for the application which would be released for public comment and further advice from experts, agencies, and authorities in September 2022. At least 30 days will be given for the submission of comments.

For more information, including the notice of the application, questions and answers, and a summary of the license application, visit the DIR 191 page on the OGTR website.

You might also like: